Mark McKenna is the founder of Prometheus Biosciences. Prometheus Biosciences has raised $400M in total funding. Latest round: Series A.
Mark C. McKenna was the President and Chief Executive Officer of Prometheus Biosciences, which was acquired by Merck for $10.8 billion in April 2023. He is now the Co-founder and CEO of Mirador Therapeutics, a new biotech company focused on precision medicines for inflammatory and fibrotic diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library